Self harm and attempted suicide in adults: 10 practical questions and answers for emergency department staff.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2579493)

Published in Emerg Med J on April 01, 2006

Authors

A J Mitchell1, M Dennis

Author Affiliations

1: Department of Liaison Psychiatry, Leicester General Hospital, Leicester, UK. alex.mitchell@leicspart.nhs.uk

Articles cited by this

Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry (1991) 6.14

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ (2005) 4.74

Trends in deliberate self-harm in Oxford, 1985-1995. Implications for clinical services and the prevention of suicide. Br J Psychiatry (1997) 4.65

Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry (2004) 3.92

Management of deliberate self poisoning in adults in four teaching hospitals: descriptive study. BMJ (1998) 3.68

Randomised controlled trial of brief psychological intervention after deliberate self poisoning. BMJ (2001) 3.46

A randomized controlled trial of postcrisis suicide prevention. Psychiatr Serv (2001) 3.37

Attendance at the accident and emergency department in the year before suicide: retrospective study. Br J Psychiatry (2003) 3.00

Suicide after deliberate self-harm: a 4-year cohort study. Am J Psychiatry (2005) 2.97

Mental disorders and comorbidity in suicide. Am J Psychiatry (1993) 2.96

Relation between parasuicide, suicide, psychiatric admissions, and socioeconomic deprivation. BMJ (1995) 2.83

General practice based intervention to prevent repeat episodes of deliberate self harm: cluster randomised controlled trial. BMJ (2002) 2.57

Postcards from the EDge project: randomised controlled trial of an intervention using postcards to reduce repetition of hospital treated deliberate self poisoning. BMJ (2005) 2.29

Why are suicide rates rising in young men but falling in the elderly?-- a time-series analysis of trends in England and Wales 1950-1998. Soc Sci Med (2003) 2.24

The efficacy of problem-solving treatments after deliberate self-harm: meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychol Med (2001) 2.22

Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16

Repetition of deliberate self-harm and subsequent suicide risk: long-term follow-up study of 11,583 patients. Br J Psychiatry (2004) 2.07

Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides. Acta Psychiatr Scand (2005) 2.06

Crisis telephone consultation for deliberate self-harm patients: effects on repetition. Br J Psychiatry (1999) 2.03

Death and dependence: current controversies over the selective serotonin reuptake inhibitors. J Psychopharmacol (2003) 1.86

Variations in the hospital management of self harm in adults in England: observational study. BMJ (2004) 1.83

Dialectical behavior therapy adapted for suicidal adolescents. Suicide Life Threat Behav (2002) 1.68

Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Am J Psychiatry (1998) 1.67

Long-term risk factors for suicide mortality after attempted suicide--findings of a 14-year follow-up study. Acta Psychiatr Scand (2001) 1.59

Repetition of parasuicide: an epidemiological and clinical study. Br J Psychiatry (1988) 1.56

Reasons for deliberate self-harm: comparison of self-poisoners and self-cutters in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry (2004) 1.52

Do patients who self-harm consult their general practitioner soon after hospital discharge? A cohort study. Soc Psychiatry Psychiatr Epidemiol (2002) 1.50

Using a risk assessment matrix with mental health patients in emergency departments. Emerg Nurse (2005) 1.46

General practitioner contacts with patients before and after deliberate self harm. Br J Gen Pract (2003) 1.22

Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics (1983) 1.22

Clinical predictors of eventual suicide: a 5- to 10-year prospective study of suicide attempters. J Affect Disord (1989) 1.19

General hospital admission in the management of parasuicide. A randomised controlled trial. Br J Psychiatry (1990) 1.17

Service provision and outcome for deliberate self-poisoning in adults--results from a six centre descriptive study. Soc Psychiatry Psychiatr Epidemiol (2003) 1.11

Loss of partner and suicide risks among oldest old: a population-based register study. Age Ageing (2004) 1.09

The predictive validation of a suicide intent scale: a five year follow-up. Br J Psychiatry (1981) 1.07

Mortality and suicide after non-fatal self-poisoning: 16-year outcome study. Br J Psychiatry (2005) 1.03

Suicide in the elderly: the United Kingdom perspective. Int Psychogeriatr (1995) 1.01

Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS). J Subst Abuse Treat (2002) 1.01

Why people engage in parasuicide: a cross-cultural study of intentions. Suicide Life Threat Behav (2002) 0.97

Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Pers Disord (2004) 0.95

Physical illness and parasuicide: evidence from the European Parasuicide Study Interview Schedule (EPSIS/WHO-EURO). Int J Psychiatry Med (1999) 0.91

Life events and psychopathology in a group of suicide attempters. Psychopathology (2004) 0.91

A multivariate study of predictors of repeat parasuicide. Acta Psychiatr Scand (2004) 0.88

Self-harm in older people with depression: comparison of social factors, life events and symptoms. Br J Psychiatry (2005) 0.86

Problems reported by self-harm patients: perception, hopelessness, and suicidal intent. J Psychosom Res (2002) 0.85

History of deliberate self-harm and its association with mood fluctuation. J Affect Disord (2004) 0.80

Can the Edinburgh Risk of Repetition Scale predict repetition of deliberate self-poisoning in an Australian clinical setting? Suicide Life Threat Behav (2002) 0.80

Recent life events and attempted suicide. J Affect Disord (1990) 0.79

Deliberate self harm (and attempted suicide). Clin Evid (2005) 0.76

Articles by these authors

(truncated to the top 100)

Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98

Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet (2009) 4.50

Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A (2000) 4.46

Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet (2013) 4.04

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med (1996) 2.96

Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project) BMJ (1992) 2.45

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med (1995) 2.23

Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol (1994) 2.22

Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci U S A (1986) 2.06

Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke (1994) 2.00

Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke (1997) 1.94

Mood disorders in the year after first stroke. Br J Psychiatry (1991) 1.93

Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther (2012) 1.89

Depression after stroke and lesion location: a systematic review. Lancet (2000) 1.87

Gluten-free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Diet (2005) 1.81

Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol (1994) 1.77

Emotionalism after stroke. BMJ (1989) 1.76

Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry (2004) 1.72

Neurological emergencies: acute stroke. J Neurol Neurosurg Psychiatry (2000) 1.62

The intelligence of hydrocephalic children. Arch Neurol (1981) 1.60

Hospital services for patients with acute stroke in the United Kingdom: the Stroke Association Survey of consultant opinion. Age Ageing (1995) 1.59

Further evidence that the KIAA0319 gene confers susceptibility to developmental dyslexia. Mol Psychiatry (2006) 1.54

Poor reading comprehension despite fast word decoding in children with hydrocephalus. Brain Lang (2001) 1.53

Systematic review of prognostic models in patients with acute stroke. Cerebrovasc Dis (2001) 1.52

A reproducible animal model of acute bleeding ulcer-the "ulcer maker". Gastroenterology (1976) 1.52

Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection. AIDS Res Hum Retroviruses (1997) 1.48

Outcome of deliberate self-poisoning. An examination of risk factors for repetition. Br J Psychiatry (1994) 1.45

The war against error: a 15 year experience of completion angioscopy following carotid endarterectomy. Eur J Vasc Endovasc Surg (2011) 1.45

Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains. Biochemistry (1987) 1.45

Lack of correspondence between the amplitudes of spontaneous potentials and unit potentials evoked by nerve impulses at regenerating neuromuscular junctions. Nat New Biol (1971) 1.41

Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased? Stroke (1997) 1.38

Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ (1997) 1.34

Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. Stroke (1998) 1.34

Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses (1993) 1.34

The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry (1990) 1.31

The effects of knowledge availability and knowledge accessibility on coherence and elaborative inferencing in children from six to fifteen years of age. J Exp Child Psychol (1996) 1.29

Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. J Biol Chem (1992) 1.27

Self-poisoning patients discharged from accident and emergency: risk factors and outcome. J R Coll Physicians Lond (1991) 1.26

Mathematical basis of point-area deconvolution method for determining in vivo input functions. J Pharm Sci (1978) 1.25

A prospective comparative study of five measures of gluten-free diet adherence in adults with coeliac disease. Aliment Pharmacol Ther (2007) 1.24

Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol (1994) 1.20

How do scores on the EuroQol relate to scores on the SF-36 after stroke? Stroke (1999) 1.16

Diurnal variation in incidence of stroke: Oxfordshire community stroke project. BMJ (1992) 1.14

Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet (1992) 1.13

Functional outcome in young adults with spina bifida and hydrocephalus. Childs Nerv Syst (2005) 1.13

Suicidal ideation, self-harm and attempted suicide: results from the British psychiatric morbidity survey 2000. Eur Psychiatry (2010) 1.11

Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry (1993) 1.09

Taking acute stroke care seriously. In the absence of evidence we should manage acute stroke as a medical emergency. BMJ (2001) 1.05

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity. J Gen Virol (2001) 1.04

Clinical evaluation of cephaloridine. Antimicrob Agents Chemother (Bethesda) (1965) 1.02

Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells. J Neurochem (1994) 1.00

Homelessness and gender in out-of-treatment drug users. Am J Drug Alcohol Abuse (2000) 1.00

Comprehension of syntax in infantile hemiplegics after cerebral hemidecortication: left-hemisphere superiority. Brain Lang (1975) 1.00

A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess (2002) 0.99

Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke? United Kingdom Collaborators in the International Stroke Trial. J Neurol Neurosurg Psychiatry (2000) 0.98

Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates. Immunology (2000) 0.97

The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol (2000) 0.96

Hemispherectomy for Sturge-Weber syndrome. Childs Brain (1979) 0.96

Development and reliability of the Royal College of Physicians stroke audit form. UK Stroke Audit Group. Age Ageing (1994) 0.96

The effect of route of immunization on mucosal immunity and protection. J Infect Dis (1999) 0.96

Life events and difficulties preceding stroke. J Neurol Neurosurg Psychiatry (1990) 0.95

Prenyl modification of guanine nucleotide regulatory protein gamma 2 subunits is not required for interaction with the transducin alpha subunit or rhodopsin. Proc Natl Acad Sci U S A (1993) 0.95

Endoscopic laser treatment. III. Development and testing of a gas-jet-assisted argon laser waveguide in control of bleeding experimental ulcers. Gastroenterology (1978) 0.95

ICLAS Working Group on Harmonization: international guidance concerning the production care and use of genetically-altered animals. Lab Anim (2013) 0.94

Endoscopic laser treatment. II. Comparison of the efficacy of high and low power photocoagulation in control of severely bleeding experimental ulcers in dogs. Gastroenterology (1977) 0.93

Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States. Aliment Pharmacol Ther (2009) 0.93

Impaired sensory and motor differentiation with corpus callosum agenesis: a lack of callosal inhibition during ontogeny? Neuropsychologia (1976) 0.93

Discourse after early-onset hydrocephalus: core deficits in children of average intelligence. Brain Lang (1998) 0.92

Reading in children and adolescents after early onset hydrocephalus and in normally developing age peers: phonological analysis, word recognition, word comprehension, and passage comprehension skill. J Pediatr Psychol (1992) 0.92

Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol. Br J Clin Pharmacol (1981) 0.92

Detecting psychiatric morbidity after stroke: comparison of the GHQ and the HAD Scale. Stroke (1998) 0.91

Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr (1976) 0.91

CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood (2001) 0.90

External validation of a six simple variable model of stroke outcome and verification in hyper-acute stroke. J Neurol Neurosurg Psychiatry (2007) 0.89

Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON). Acta Oncol (1994) 0.89

Patients' and carers' satisfaction with acute stroke management. Age Ageing (1995) 0.89

Saccades in children with spina bifida and Chiari type II malformation. Neurology (2005) 0.89

The heater probe: a new endoscopic method for stopping massive gastrointestinal bleeding. Gastroenterology (1978) 0.89

Mood disorders after stroke and their relation to lesion location. A CT scan study. Brain (1990) 0.89

Assessing the impact of the requirement for explicit consent in a hospital-based stroke study. QJM (2008) 0.88

Screening for postnatal depression: barriers to success. BJOG (2008) 0.87

Mucosal exposure to subinfectious doses of SIV primes gut-associated antibody-secreting cells and T cells: lack of enhancement by nonneutralizing antibody. Virology (2001) 0.87

Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: comparison with an age dependent rise in normal human males. Acta Endocrinol (Copenh) (1977) 0.86

In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha,17beta-diol and of 3-h-5alpha-androstane-3beta,17beta-diol by human prostatic hypertrophy. Acta Endocrinol (Copenh) (1975) 0.86

Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol Pharmacol (1995) 0.86

Observation and discrimination learning in the rat: specific and nonspecific effects. J Comp Physiol Psychol (1972) 0.85

Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques. AIDS (1998) 0.85

Language acquisition following hemidecortication: linguistic superiority of the left over the right hemisphere. Brain Lang (1976) 0.85

Music skills and the expressive interpretation of music in children with Williams-Beuren syndrome: pitch, rhythm, melodic imagery, phrasing, and musical affect. Child Neuropsychol (2001) 0.84

Electrically evoked release of acetylcholine from Schwann cells at denervated motor end-plates. J Physiol (1972) 0.84

An approach to training and retaining primary care physicians in rural Appalachia. Acad Med (1993) 0.82

Etiology of intellectual impairment in Duchenne muscular dystrophy. Pediatr Neurol (1990) 0.82

Prediction of outcome after stroke. Lancet (2001) 0.82

Expression and pharmacological characterization of the human M1 muscarinic receptor in Saccharomyces cerevisiae. FEBS Lett (1990) 0.82

Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Dev Biol Stand (1998) 0.82

Somatodendritic internalization and perinuclear targeting of neurotensin in the mammalian brain. J Neurosci (1995) 0.82

Improvements in carotid endarterectomy in Scotland: results of a national prospective survey. Scott Med J (2004) 0.81

An evaluation of the nurse practitioner role in a major rural emergency department. J Adv Nurs (1999) 0.81